Morgan Stanley
MGX icon

Morgan Stanley’s Metagenomi Therapeutics MGX Stock Holding History

Morgan Stanley’s Portfolio MGX Stock Details MGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.9K Sell
27,566
-32,116
-54% -$49.9K ﹤0.01% 6528
2025
Q4 		$96.7K Sell
59,682
-181,652
-75% -$393K ﹤0.01% 6219
2025
Q3 		$572K Sell
241,334
-8,853
-4% -$18K ﹤0.01% 5445
2025
Q2 		$370K Buy
250,187
+56,434
+29% +$88.4K ﹤0.01% 5600
2025
Q1 		$264K Sell
193,753
-582,033
-75% -$1.39M ﹤0.01% 5619
2024
Q4 		$2.8M Buy
775,786
+711,149
+1,100% +$1.72M ﹤0.01% 4452
2024
Q3 		$140K Buy
64,637
+19,919
+45% +$69.1K ﹤0.01% 5875
2024
Q2 		$182K Buy
44,718
+35,513
+386% +$244K ﹤0.01% 5725
2024
Q1 		$97.1K Buy
+9,205
New +$106K ﹤0.01% 6005

Other funds holding MGX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return